Eva Corey

70PUBLICATIONS

423CO-AUTHORS

Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisAccelerators

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (70)

Sort by Publication Date:

|May 26, 2026

Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer.

|May 12, 2026

TMPRSS2-ERG confers resistance of prostate cancer to antiandrogens.

|Feb 14, 2026

FOXJ1 mediates taxane resistance through regulation of microtubule dynamics.

Fang Xie, Ada Gjyrezi, Daniel Fein

|Jan 27, 2026

Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.

Nicole A Traphagen, Esmé Wheeler, Rong Li

|Dec 31, 2025

The Olive Phenolic <i>S</i>-(-)-Oleocanthal as a Novel Intervention for Neuroendocrine Prostate Cancers: Therapeutic and Molecular Insights.

Md Towhidul Islam Tarun, Hassan Y Ebrahim, Dalal Dawud

|Dec 11, 2025

BPTF regulates androgen receptor activity by enhancing chromatin accessibility and stabilizing the AR-FOXA1 interaction.

Hee-Young Jeon, Sudeep Khadka, Majid Pornour

Pageof 12

Frequent Collaborators

14 joint publications

Peter S Nelson

Michael C Haffner

John K Lee

Brian Hanratty

Steven P Balk

Navonil DeSarkar

Mark P Labrecque

Gavin Ha

Ilsa M Coleman

Colm Morrissey

Frequent Collaborators

14 joint publications

Peter S Nelson

8 joint publications

Michael C Haffner

7 joint publications

John K Lee

6 joint publications

Brian Hanratty